Fathom Digital Manufacturing Reports Second Quarter 2023 Financial Results
Second Quarter 2023 Highlights Revenue totaled $34.5 million Total orders were $38.0 million Net loss…
Second Quarter 2023 Highlights Revenue totaled $34.5 million Total orders were $38.0 million Net loss…
Healthcare services non-profit achieves over 73 percent cost savings using Rubrik data security solutions alongside…
New automated features elevate the standard of care for NeuroStar® Advanced Therapy practices MALVERN, Pa.,…
New automated features elevate the standard of care for NeuroStar® Advanced Therapy practices MALVERN, Pa.,…
Lead Asset KET01, an Oral Prolonged-Release Ketamine Formulation, Demonstrated Early Improvements in Depressive Severity Key…
Lead Asset KET01, an Oral Prolonged-Release Ketamine Formulation, Demonstrated Early Improvements in Depressive Severity Key…
– Grace Breeding’s environmentally friendly proprietary NFT biofertilizer (Maoz™) receives first approval in Brazil and…
– Grace Breeding’s environmentally friendly proprietary NFT biofertilizer (Maoz™) receives first approval in Brazil and…
Renowned scientist will advise on the development of IMUNON’s FixPlas and IndiPlas modalities in immuno-oncology…
Renowned scientist will advise on the development of IMUNON’s FixPlas and IndiPlas modalities in immuno-oncology…
Earl Douglas General Counsel, Allogene Therapeutics SOUTH SAN FRANCISCO, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE)…
Earl Douglas General Counsel, Allogene Therapeutics SOUTH SAN FRANCISCO, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE)…
YONKERS, N.Y., Aug. 14, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
YONKERS, N.Y., Aug. 14, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
JENKINTOWN, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) — SFA Therapeutics, a clinical-stage biotech using a first-in-class…
JENKINTOWN, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) — SFA Therapeutics, a clinical-stage biotech using a first-in-class…
Announced today that all 3 patients (100% response rate) treated with ELX-02 showed an improvement in…
Announced today that all 3 patients (100% response rate) treated with ELX-02 showed an improvement in…
Tel Aviv, Israel / Vancouver, Canada, Aug. 14, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
Tel Aviv, Israel / Vancouver, Canada, Aug. 14, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….